Tandem Diabetes Care, Inc. (TNDM) — Financial statements
Income statement, balance sheet, and cash flow for Tandem Diabetes Care, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 1,015↑7.9% | 940↑25.7% | 748↓6.7% | 801↑14.0% | 703 | |
| Cost of Revenue | 484↑7.4% | 451↑18.6% | 380↓2.1% | 388↑18.9% | 327 | |
| Gross Profit | 531↑8.4% | 490↑33.1% | 368↓11.0% | 413↑9.8% | 376 | |
| Operating Expenses | ||||||
| R&D Expenses | 175↓12.1% | 199↓19.9% | 248↑46.0% | 170↑84.8% | 92 | |
| General & Administrative Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 434↑11.4% | 390↑10.6% | 353↑5.0% | 336↑28.4% | 262 | |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | 609↑3.4% | 589↓2.0% | 601↑18.8% | 506↑43.1% | 354 | |
| Total Costs & Expenses | 1,093↑5.2% | 1,039↑6.0% | 981↑9.7% | 894↑31.5% | 680 | |
| Operating Results | ||||||
| Operating Income | -78↑21.2% | -99↑57.5% | -233↓151.2% | -93↓509.9% | 23 | |
| Depreciation & Amortization | 18↑11081.0% | 0.16↓99.0% | 16↑9.7% | 14↑3.5% | 14 | |
| EBITDA | -175↓76.2% | -99↑49.5% | -196↓164.7% | -74↓317.9% | 34 | |
| EBIT | -192↓93.8% | -99↑53.2% | -212↓139.6% | -89↓538.0% | 20 | |
| Interest & Other Income | ||||||
| Net Interest Income | 1↓88.9% | 11↓18.5% | 13↑8693.4% | -0.15↑97.2% | -5 | |
| Interest Income | 9↓49.5% | 18↓21.3% | 23↑277.4% | 6↑798.7% | 0.67 | |
| Interest Expense | 8↑6.6% | 7↓25.0% | 10↑59.2% | 6↑2.8% | 6 | |
| Non-Operating Income | 114↑72205.7% | 0.16↑100.8% | -21↓388.6% | -4↓276.7% | 2 | |
| Other Income / Expenses | -122↓1783.2% | 7↓44.1% | 13↑324500.0% | -0.00↑99.9% | -7 | |
| Income Before Tax | -200↓118.0% | -92↑58.3% | -220↓137.2% | -93↓683.9% | 16 | |
| Income Tax Expense | 4↑6.8% | 4↑76.3% | 2↑35.3% | 2↑420.0% | 0.34 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -205↓113.2% | -96↑56.9% | -223↓135.3% | -95↓707.7% | 16 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -205↓113.2% | -96↑56.9% | -223↓135.3% | -95↓707.7% | 16 | |
| Bottom-Line Net Income | -205↓113.2% | -96↑56.9% | -223↓135.3% | -95↓707.7% | 16 | |
| EPS (Basic) | -3.04↓106.8% | -1.47↑57.1% | -3.43↓133.3% | -1.47↓688.0% | 0.25 | |
| EPS (Diluted) | -3.04↓106.8% | -1.47↑57.1% | -3.43↓133.3% | -1.47↓712.5% | 0.24 | |
| Weighted Average Shares | 67↑2.8% | 65↑0.8% | 65↑1.2% | 64↑1.8% | 63 | |
| Weighted Average Diluted Shares | 67↑2.8% | 65↑0.7% | 65↑1.3% | 64↓0.3% | 64 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.